The global experience of the potential of gastric cancer screening at the age of >50 years, including by H.pylori SAT will be analyzed. Protocol for a study combining FIT to SAT will be developed; relevant approvals, including from
ethical boards, will be secured; and initial pilot study will be conducted to address feasibility of this approach in the EU. Altogether ≥1000 subjects will be invited to participate in 4 centres in Europe. Invitations will be sent to individuals ≥50 years; stool samples will be collected by the participants in home conditions and delivered to a centralised laboratory. Those testing positive for H.pylori will get invited to the study centre. Standardised survey questions will be used to collect information on previous medical history and lifestyle factors; and offered H.pylori eradication medication. One month after treatment, the effectiveness will be tested by a C-urea breath test (UBT), and data on the potential adverse events will be surveyed. A proportion of non-responders will be surveyed using a
telephone interview.
This task will be led by LU, Latvia.